Table 3.
Characteristics of four patients who died.
| Patient number | Induction regimen | Complication during induction | Cycle in which the patient died | Complications | Time of death⁎⁎ | Cause of death |
|---|---|---|---|---|---|---|
| 1 | Cytarabine + daunorubicin | Fusariosis | 1 | Typhlitis, Clostridioides difficile colitis | 20 | Septic shock |
| 2 | Cytarabine + daunorubicin | Bacteremia viridans Streptococcus | 1 | Candidemia due to Candida tropicalis, septic shock | 15 | Septic shock |
| 3 | Cytarabine + mitoxantrone | None | 3 | DIC related to relapse and disease progression | 17 | Disease progression |
| 4 | Cytarabine + daunorubicin | Bacteremia CONS | 2 | Typhlitis | 44 | Disease progression |
DIC = disseminated intravascular coagulation; CONS = coagulase-negative staphylococci.
Time of death related to the first day of the cycle of high-dose cytarabine.